These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34921522)

  • 1. Urinary liver-type fatty acid-binding protein as a prognostic marker in patients with acute heart failure.
    Sunayama T; Yatsu S; Matsue Y; Dotare T; Maeda D; Ishiwata S; Nakamura Y; Suda S; Kato T; Hiki M; Kasai T; Minamino T
    ESC Heart Fail; 2022 Feb; 9(1):442-449. PubMed ID: 34921522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of urinary liver-type fatty acid-binding protein as a prognostic marker in adult congenital heart patients hospitalized for acute heart failure.
    Wakisaka Y; Inai K; Sato M; Harada G; Asagai S; Shimada E
    Heart Vessels; 2023 Mar; 38(3):371-380. PubMed ID: 36169710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis.
    Juanola A; Graupera I; Elia C; Piano S; Solé C; Carol M; Pérez-Guasch M; Bassegoda O; Escudé L; Rubio AB; Cervera M; Napoleone L; Avitabile E; Ma AT; Fabrellas N; Pose E; Morales-Ruiz M; Jiménez W; Torres F; Crespo G; Solà E; Ginès P
    J Hepatol; 2022 Jan; 76(1):107-114. PubMed ID: 34530063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Urinary Liver-Type Fatty Acid-Binding Protein Level Predicts Worsening Renal Function in Patients With Acute Heart Failure.
    Okubo Y; Sairaku A; Morishima N; Ogi H; Matsumoto T; Kinoshita H; Kihara Y
    J Card Fail; 2018 Aug; 24(8):520-524. PubMed ID: 30026130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy.
    Hofstra JM; Deegens JK; Steenbergen EJ; Wetzels JF
    Nephrol Dial Transplant; 2008 Oct; 23(10):3160-5. PubMed ID: 18403431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and prognostic values of urinary alpha1-microglobulin as a tubular marker in acute heart failure.
    Ishiwata S; Matsue Y; Nakamura Y; Dotare T; Sunayama T; Suda S; Yatsu S; Kato T; Hiki M; Kasai T; Minamino T
    Int J Cardiol; 2021 Sep; 338():115-120. PubMed ID: 34181994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2.
    Maeda Y; Suzuki A; Ishii J; Sekiguchi-Ueda S; Shibata M; Yoshino Y; Asano S; Hayakawa N; Nakamura K; Akiyama Y; Kitagawa F; Sakuishi T; Fujita T; Hashimoto S; Ozaki Y; Itoh M
    Heart Vessels; 2015 May; 30(3):362-8. PubMed ID: 24626813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease.
    Kamijo A; Kimura K; Sugaya T; Yamanouchi M; Hikawa A; Hirano N; Hirata Y; Goto A; Omata M
    J Lab Clin Med; 2004 Jan; 143(1):23-30. PubMed ID: 14749682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver fatty-acid-binding protein in heart and kidney allograft recipients in relation to kidney function.
    Przybylowski P; Koc-Zorawska E; Malyszko JS; Kozlowska S; Mysliwiec M; Malyszko J
    Transplant Proc; 2011 Oct; 43(8):3064-7. PubMed ID: 21996226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes.
    Panduru NM; Forsblom C; Saraheimo M; Thorn LM; Gordin D; Elonen N; Harjusalo V; Bierhaus A; Humpert PM; Groop PH;
    Diabetologia; 2017 Sep; 60(9):1782-1790. PubMed ID: 28601908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary liver-type fatty acid-binding protein in pediatric nephrotic syndrome and tubular dysfunction.
    Nishida M; Kawakatsu H; Hamaoka K
    Pediatr Int; 2018 May; 60(5):442-445. PubMed ID: 29460503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Urinary Liver-Type Fatty Acid-Binding Protein Level Predicts Major Adverse Cardiovascular Events in Patients With Hypertension.
    Okubo Y; Nakano Y; Tokuyama T; Hironobe N; Okamura S; Ikeuchi Y; Miyauchi S; Kihara Y
    Am J Hypertens; 2020 Jul; 33(7):604-609. PubMed ID: 32155236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of urinary liver-type fatty acid-binding protein with cardiovascular risk factors in the Japanese population without chronic kidney disease: Sasayama study.
    Kubota Y; Higashiyama A; Marumo M; Konishi M; Yamashita Y; Okamura T; Miyamoto Y; Wakabayashi I
    BMC Nephrol; 2021 May; 22(1):189. PubMed ID: 34020611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
    Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of tubular and podocyte biomarkers in acute kidney injury.
    Matsui K; Kamijo-Ikemori A; Hara M; Sugaya T; Kodama T; Fujitani S; Taira Y; Yasuda T; Kimura K
    Clin Exp Nephrol; 2011 Apr; 15(2):220-5. PubMed ID: 21153750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urinary fatty acid binding protein as a new clinical marker for the progression of chronic renal disease].
    Kamijo A; Sugaya T; Hikawa A; Kimura K
    Rinsho Byori; 2003 Mar; 51(3):219-24. PubMed ID: 12707994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine liver fatty acid binding protein and chronic kidney disease progression.
    Khatir DS; Bendtsen MD; Birn H; Nørregaard R; Ivarsen P; Jespersen B; Buus NH
    Scand J Clin Lab Invest; 2017 Nov; 77(7):549-554. PubMed ID: 28745927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus.
    Fufaa GD; Weil EJ; Nelson RG; Hanson RL; Bonventre JV; Sabbisetti V; Waikar SS; Mifflin TE; Zhang X; Xie D; Hsu CY; Feldman HI; Coresh J; Vasan RS; Kimmel PL; Liu KD;
    Diabetologia; 2015 Jan; 58(1):188-98. PubMed ID: 25316431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting acute kidney injury using urinary liver-type fatty-acid binding protein and serum N-terminal pro-B-type natriuretic peptide levels in patients treated at medical cardiac intensive care units.
    Naruse H; Ishii J; Takahashi H; Kitagawa F; Nishimura H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Hayashi M; Sarai M; Watanabe E; Izawa H; Ozaki Y
    Crit Care; 2018 Aug; 22(1):197. PubMed ID: 30119691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary L-FABP and its combination with urinary NGAL in early diagnosis of acute kidney injury after cardiac surgery in adult patients.
    Liu S; Che M; Xue S; Xie B; Zhu M; Lu R; Zhang W; Qian J; Yan Y
    Biomarkers; 2013 Feb; 18(1):95-101. PubMed ID: 23167703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.